Physician

Mark E Burnett, M.D.

According to 2025 Medicare claims, Mark Burnett, M.D. (NPI: 1104182393) practices micrographic dermatologic surgery in the Santa Maria-Santa Barbara, CA market, with the plurality of this provider's patient population coming from Santa Barbara, CA. This provider's primary affiliated billing organization is CALIFORNIA DERMATOLOGY GROUP PC (NPI: 1104405943; TIN: 832181559) and primary practice location at 93105-4276.

Burnett's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,800 traditional Medicare patients, billed 17,471 HCPCS/CPT codes, and received $1,875,734 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 450 prescription claims across 253 beneficiaries totaling $18,188 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 16 records totaling $431. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $80,816 to $1,875,734. Similarly, Part D prescription costs have moved sharply higher in recent years, from $9,935 to $18,188. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	79	343	$80,816
2018	413	1,731	$353,977
2019	707	4,052	$759,289
2020	634	4,230	$697,942
2021	472	3,071	$503,752
2022	774	5,077	$832,659
2023	1,434	11,851	$1,399,799
2024	1,800	17,471	$1,875,734

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	56	141	$9,935
2016	19	33	$3,457
2017	N/R	19	$342
2018	N/R	N/R	N/R
2019	116	169	$3,810
2020	263	400	$6,962
2021	235	347	$72,236
2022	194	298	$49,493
2023	191	364	$58,897
2024	253	450	$18,188

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,025	1,760	$97
11102	Biopsy of related skin growth, first growth	695	967	$72
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	651	1,033	$68
17000	Destruction of precancer skin growth, 1 growth	842	1,363	$39
17003	Destruction of precancer skin growth, 2-14 growths	671	5,019	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Clobetasol Propionate	Clobetasol Propionate	49	1,357	$2,030
Mupirocin	Mupirocin	115	2,501	$847
Fluocinonide	Fluocinonide	14	412	$513
Ketoconazole	Ketoconazole	28	809	$320
Cephalexin	Cephalexin	31	226	$311

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$431	SUN PHARMACEUTICAL INDUSTRIES INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark E. Burnett, M.D.?

Tedicare shows public-source Medicare data for Mark E. Burnett, M.D. (NPI 1104182393), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark E. Burnett, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark E. Burnett, M.D.?

Mark E. Burnett, M.D. is linked to CALIFORNIA DERMATOLOGY GROUP PC (billing NPI 1104405943) in the available physician profile data.

Does Mark E. Burnett, M.D. have Open Payments data?

Mark E. Burnett, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.